id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-0026-0018,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2022-10-07T04:00:00Z,2022,10,2022-10-07T04:00:00Z,,2022-10-07T15:04:36Z,2022-21865,0,0,09000064853d3898
FDA-2020-N-0026-0017,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2022-10-07T04:00:00Z,2022,10,2022-10-07T04:00:00Z,,2022-10-07T14:34:49Z,2022-21851,0,0,09000064853d3853
FDA-2020-N-0026-0016,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2022-08-29T04:00:00Z,2022,8,2022-08-29T04:00:00Z,,2022-08-29T19:19:19Z,2022-18519,0,0,0900006485285365